OCGN Q3 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-69.3% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$13M-1166.5% margin

Net Income

-$13M-1141.7% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-0.4%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$21M

Stockholders' Equity

$41M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$4M	-69.3%
Gross Profit	$1M	-$3M	+133.9%
Operating Income	-$13M	-$12M	-6.6%
Net Income	-$13M	-$12M	-10.7%